State Street’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-348,114
| Closed | -$7.52M | – | 4877 |
|
|
2022
Q4 | $7.52M | Sell |
348,114
-2,430
| -0.7% | -$51.4K | ﹤0.01% | 2857 |
|
|
2022
Q3 | $6.79M | Sell |
350,544
-1,073,799
| -75% | -$22.2M | ﹤0.01% | 2912 |
|
|
2022
Q2 | $28.3M | Buy |
1,424,343
+515,615
| +57% | +$13.6M | ﹤0.01% | 1996 |
|
|
2022
Q1 | $27.1M | Sell |
908,728
-84,104
| -8% | -$2.46M | ﹤0.01% | 2178 |
|
|
2021
Q4 | $23.1M | Sell |
992,832
-62,079
| -6% | -$1.65M | ﹤0.01% | 2377 |
|
|
2021
Q3 | $32.9M | Buy |
1,054,911
+209,428
| +25% | +$6.48M | ﹤0.01% | 2113 |
|
|
2021
Q2 | $29.7M | Sell |
845,483
-156,177
| -16% | -$5.08M | ﹤0.01% | 2233 |
|
|
2021
Q1 | $35.3M | Buy |
1,001,660
+219,895
| +28% | +$8.12M | ﹤0.01% | 1994 |
|
|
2020
Q4 | $29.3M | Buy |
781,765
+558,117
| +250% | +$20.3M | ﹤0.01% | 1995 |
|
|
2020
Q3 | $7.46M | Sell |
223,648
-2,976
| -1% | -$86.7K | ﹤0.01% | 2597 |
|
|
2020
Q2 | $6M | Buy |
226,624
+6,709
| +3% | +$158K | ﹤0.01% | 2666 |
|
|
2020
Q1 | $3.6M | Buy |
219,915
+26,289
| +14% | +$578K | ﹤0.01% | 2787 |
|
|
2019
Q4 | $4.92M | Sell |
193,626
-1,126
| -0.6% | -$22.5K | ﹤0.01% | 2857 |
|
|
2019
Q3 | $3.9M | Buy |
194,752
+18,340
| +10% | +$475K | ﹤0.01% | 2914 |
|
|
2019
Q2 | $5.69M | Buy |
176,412
+34,304
| +24% | +$1.15M | ﹤0.01% | 2754 |
|
|
2019
Q1 | $4.58M | Buy |
142,108
+2,941
| +2% | +$79.2K | ﹤0.01% | 2789 |
|
|
2018
Q4 | $3.41M | Sell |
139,167
-7,013
| -5% | -$185K | ﹤0.01% | 2894 |
|
|
2018
Q3 | $4.82M | Buy |
146,180
+5,868
| +4% | +$192K | ﹤0.01% | 2886 |
|
|
2018
Q2 | $4.98M | Buy |
+140,312
| New | +$4.54M | ﹤0.01% | 2852 |
|
Other funds holding ALBO
State Street's ALBO Position: Q1 2023 in Review
State Street sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 348,114 shares — an estimated $7.52M sold.
State Street first reported a position in ALBO in Q2 2018 and held it in 19 quarters. The position peaked at $35.3M in Q1 2021. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.
- State Street reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
- State Street sold 348,114 Albireo Pharma Inc shares in Q1 2023, an estimated $7.52M.
- State Street first reported a position in Albireo Pharma Inc in Q2 2018 and held it in 19 quarters.
- State Street's Albireo Pharma Inc position peaked at $35.3M in Q1 2021.
- 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.
Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.